Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

WNS Launches PRECIZON to Deliver Cloud-based Competitive Intelligence for Life Sciences Industry

By: WNS (Holdings) Limited via Business Wire

August 03, 2021 at 08:00 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

WNS (Holdings) Limited (NYSE: WNS), a leading provider of global Business Process Management (BPM) solutions, today announced the formal introduction of PRECIZON, the company’s cloud-based Competitive Intelligence (CI) platform for the Pharma, Bio-pharma and Life Sciences industry. PRECIZON provides companies with real-time CI curated from commercial and public data sources, and analyzed/presented using rich visualization techniques. The solution gives companies unprecedented access to granular data, advanced domain-centric analytics, and actionable insights resulting in enhanced decision-making and improved competitive positioning.

PRECIZON is customizable, scalable and easy-to-use, powered by WNS’ deep Pharma expertise and state-of-the-art Artificial Intelligence (AI) / Machine Learning (ML) models contextualized to CI needs. The robust AI / ML layer enables intelligence across the platform by collecting user-centric content and driving engagement. PRECIZON leverages complex search algorithms to evaluate the market landscape and drug approval timelines of competitors, providing Pharma companies with intelligent recommendations and unique views of the competitive landscape.

“Access to accurate, broad-based data sources and relevant analytical insights can give pharma companies a strategic advantage as they adapt to a complex market landscape, pricing pressures and evolving customer expectations. PRECIZON allows companies to prioritize R&D spends with a 360-degree real-time view shaped by agility, intelligent search algorithms, modularity and easy enterprise-wide access,” said Keshav R. Murugesh, Group CEO, WNS.

The platform is customizable for personalized reporting, easily integrated with existing commercial data and BI tools, and accessible across devices.

About WNS

WNS (Holdings) Limited (NYSE: WNS) is a leading Business Process Management (BPM) company. WNS combines deep industry knowledge with technology, analytics and process expertise to co-create innovative, digitally led transformational solutions with over 380 clients across various industries. WNS delivers an entire spectrum of BPM solutions including industry-specific offerings, customer experience services, finance and accounting, human resources, procurement, and research and analytics to re-imagine the digital future of businesses. As of June 30, 2021, WNS had 46,918 professionals across 57 delivery centers worldwide including facilities in Australia, China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Spain, Sri Lanka, Turkey, the United Kingdom, and the United States. For more information, visit www.wns.com.

Safe Harbor Provision

This document includes information which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events. Factors that could cause actual results to differ materially from those expressed or implied are discussed in our most recent Form 20-F and other filings with the Securities and Exchange Commission. WNS undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210803005604/en/

Contacts

Investors:

David Mackey

EVP–Finance & Head of Investor Relations

WNS (Holdings) Limited

+1 (646) 908-2615

david.mackey@wns.com

Media:

Archana Raghuram

Global Head – Marketing & Communications and Corporate Business Development

WNS (Holdings) Limited

+91 (22) 4095 2397

archana.raghuram@wns.com ; pr@wns.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	261.26	+0.00 (0.00%)
AAPL	306.31	+0.00 (0.00%)
AMD	510.13	+0.00 (0.00%)
BAC	51.51	+0.00 (0.00%)
GOOG	372.58	+0.00 (0.00%)
META	600.47	+0.00 (0.00%)
MSFT	460.52	+0.00 (0.00%)
NVDA	224.36	+0.00 (0.00%)
ORCL	248.15	+0.00 (0.00%)
TSLA	415.88	+0.00 (0.00%)